Skin cancer vaccine BLA submitted by...?
Skin cancer vaccine BLA submitted by...?
Jul 1, 2027
$56.16K Vol.
Skin cancer vaccine BLA submitted by...?
End date: Jul 1, 2027
Outcomes
March 31, 2027
$5.99K Vol.
49%
49%
June 30, 2027?
$50.17K Vol.
60%
60%
Rules
This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET. Otherwise, this market will resolve to "No".
Comments
Comments